Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
- Development stage
- Preclinical
- Modality
- Peptides, Small Molecules
01
Overview
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide is a synthetic dipeptide derivative composed of D-leucine and L-proline, with a 3-chlorobenzyl group attached to the nitrogen atom of the proline residue. It is classified as a small molecule and has been investigated primarily as an experimental compound. Its main mechanism of action is inhibition of prothrombin, suggesting potential anticoagulant or antithrombotic activity. The compound has not been approved for any indication and remains at the investigative stage, with no clinical trials reported beyond preclinical research[1][2][8].
- Other names
- N-(3-Chlorobenzyl)-1-[(2R)-2-amino-4-methylpentanoyl]-L-prolinamide(2S)-1-[(2R)-2-amino-4-methylpentanoyl]-N-[(3-chlorophenyl)methyl]pyrrolidine-2-carboxamide
02
Targets
F2 (Thrombin)
Beyond the preview
Go deeper on D-leucyl-N-(3-chlorobenzyl)-L-prolinamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on D-leucyl-N-(3-chlorobenzyl)-L-prolinamide.